The first reported outbreak of chikungunya occurred in 1952 in Tanzania. But over the past two decades the infection has become a major public health concern, as a result of the increasing ...

Thomas Lingelbach, CEO of Valneva, said, “The current outbreak in India underscores the fact that containing chikungunya is an international public health priority. SII has extensive ...

French-Austrian drugmaker Valneva's vaccine candidate against chikungunya, a mosquito-borne virus that causes occasional outbreaks across the world, showed promising results in a large new trial ...

Thomas Lingelbach, Chief Executive Officer of Valneva, commented, “The current outbreak in India underscores the fact that containing chikungunya is an international public health priority.

Valneva has been awarded funding from the Coalition for Epidemic Preparedness Innovations (CEPI) and EU to expand access to its recently approved vaccine for chikungunya, a potentially life ...

Brazilian health authorities have expressed concern following the reappearance of the dengue virus serotype 3, particularly ...

Thomas Lingelbach, CEO of Valneva, commented, “The current outbreak in India underscores the fact that containing chikungunya is an international public health priority. SII has extensive ...

Thomas Lingelbach, Chief Executive Officer of Valneva, commented, "The current outbreak in India underscores the fact that containing chikungunya is an international public health priority. SII has ...